ArticleJournal of translational medicine2026
Autocrine PD-1-blocking nanobodies enhance the antitumor efficacy of TCR-like CAR-T cells by attenuating t cell exhaustion.
Wanjun He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.